Skip to main content

Anna Casteras Román

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Anna Casteras Román

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Diabetis i metabolisme

IP: Rafael Simó Canonge
Collaborators: Josep A Villena Delgado, Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Rosario Pardo Diaz, Angel Michael Ortiz Zúñiga, Andreea Ciudin Mihai, Fiorella Ximena Palmas Candia, Ana Maria Ortiz de Urbina Olive, Monica Sanchez Bartres, Lorena Ramos Pérez, Marc Rivas Agudo, Diabetis i metabolisme, Anna Casteras Román, Alejandra Planas Vilaseca, Betina Biagetti Biagetti, Judit Amigó Farran, Mercè Abad Martín, Marta Comas Martínez, Hugo Ramos Abellan, Rosa Burgos Peláez, David Sabater Martínez, Olga Simó Servat, Patricia Bogdanov Baruj, Maria Llorian Salvador, Enzamaría Fidilio Meli
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00655
Duration: 01/01/2022 - 30/06/2025

RECEPTORES INHBITORIOS (NEGATIVE IMMUNE CHECKPOINT RECEPTORS, NCRs) EN AUTOINMUNIDAD TIROIDEA Y CANCER, NUEVAS VÍAS TERAPÉUTICAS EN AUTOINMUNIDAD

IP: -
Collaborators: Oscar González López, Roser Ferrer Costa, Carmela Iglesias i Felip, Anna Casteras Román, Elena Garralda Cabanas, Daniel Alvarez De la Sierra
Funding agency: Instituto de Salud Carlos III
Funding: 147620
Reference: PI17/00324
Duration: 01/01/2018 - 30/06/2022

PAPEL DEL RECEPTOR DE TSH EN LOS TIMOCITOS EN EL INICIO DE LA ENFERMEDAD DE GRAVES (EG) Y MECANISMOS DE TIROIDITIS

IP: -
Collaborators: Oscar González López, Roser Ferrer Costa, Gabriel Obiols Alfonso, Anna Casteras Román, Joaquin Fernandez Doblas
Funding agency: Instituto de Salud Carlos III
Funding: 80465
Reference: PI14/00848
Duration: 01/01/2015 - 31/12/2018

Estudio de los efectos negativos de la diabetes mellitus tipo 2 sobre la función pulmonar y la respiración durante el sueño (Estudio SWEET LUNG)

IP: -
Collaborators: Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Anna Casteras Román, Olga Mestres Soler
Funding agency: Fundación Sdad Española Endocrinologia y Nutrición
Funding: 20000
Reference: FSEEN-2012-01
Duration: 04/05/2012 - 03/05/2014

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Nunzio Gennaro Cifariello

Nunzio Gennaro Cifariello

Head of unit
Business Development Unit
Directorate of Innovation and Business Development
Read more
Sara Escalera Anzola

Sara Escalera Anzola

Predoctoral researcher
Diabetes and Metabolism
Read more
Carlos Domínguez Pérez

Carlos Domínguez Pérez

Tècnic/a Grau Superior
Prevention of Labor Relations
Human Resources Directorate
Read more
María Díaz Hervás

María Díaz Hervás

Predoctoral researcher
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.